Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine CI vs PIB after Total Knee Arthroplasty
NCT03696095Phase 4Completed
- Start
- Apr 2018
- Primary completion
- Nov 2018
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain (2 arms). Primary endpoint: Frequency of unplanned analgesia interventions at 72 hours. Started Apr 2018; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03696095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03696095.